CyberKnife® Frequently Asked Questions

 

- What conditions can the CyberKnife® System treat?

- How many patients have been treated with the CyberKnife® System? 

- How does the CyberKnife® System differ from other radiosurgery systems?  

- What are the benefits of treatment with the CyberKnife® System?

- How long does the treatment take?

- Are CyberKnife® treatments covered by insurance?

 

 

What conditions can the CyberKnife® System treat?

The CyberKnife® system can treat a range of conditions, many are listed below.  Please speak to your consultant or The London Clinic for more information.

 

.... Types of tumours and lesions
 

Benign tumours 

Malignant tumours 

 

Metastases (brain and bony)

Primary (e.g. strocytomas, carcinomas, gliomas, lung, pancreas)

     
 

Intracranial tumours and lesions 

 
  Acoustic neuroma/Vestibular schwannoma   Anaplastic astrocytoma  
  Schwannoma   Arteriovenous malformation (AVM)  
  Craniopharyngioma   DNET  
  Ependymoma   Epidural hematoma
  Gangliocytoma    Germinoma   
  Glioblastoma multiforme   Glioma  
  Glomus jugulare tumor Hemangioblastoma  
  Meningioma   Neurocytoma  
  Neurofibroma   Neurofibromatosis 
  Oligodendroglioma   Pituitary adenoma 
  PNET   Trigeminal neuralgia  
     
  Extracranial tumors and lesions  
  Base of skull   Kidney
  Liver Lungs  
  Neck   Pancreas  
  Cervical Spine    Lumbar Spine  
  Sacral Spine 

Thoracic Spine

     

Other lesions, tumors, and conditions anywhere in the body when radiation treatment is   indicated.

 

 

 

How many patients have been treated with the CyberKnife® System?

 

As of September 2009, more than 80,000 patients worldwide have been treated by the CyberKnife® Robotic Radiosurgery System.

 

 

 

How does the CyberKnife® System differ from other radiosurgery systems?

 

Radiosurgery has traditionally been restricted to the treatment of tumours in the brain. Patients undergoing traditional radiosurgery for brain tumours are fitted with a rigid metal frame bolted to the skull. This steadies the head during the treatment so that the high doses of radiation can be more precisely targeted at the tumour with minimal damage to other parts of the brain or structures in the head. These frames cause considerable discomfort, may limit the angles from which radiation can be delivered, and make treatment in more than one session difficult.

 

The CyberKnife® System is the first and only intelligent robotic radiosurgery system that uses a combination of image guidance and computer controlled robotics to continuously track, detect and correct for tumour and patient movements throughout the treatment. It delivers radiation with pinpoint sub-millimetre accuracy anywhere in the body including tumours in or near the head, spine, lung, prostate, pancreas and liver. Because of the extreme precision and accuracy of the CyberKnife® System, no invasive head or body frame is required.

 

 

 

What are the benefits of treatment with the CyberKnife® System?

 

* More treatment options — The CyberKnife® System gives new hope to patients with

   previously inoperable tumours or those who refuse surgery as a new treatment option

   approved to treat tumours anywhere in the body.

* Autonomous delivery — continuously tracks the tumour position, detects the tumour’s

   location and corrects for tumour and patient movement throughout the treatment.  

* Precision — The CyberKnife® System delivers high-dose radiation with sub-millimetre

  accuracy, minimising damage to surrounding healthy tissue.  

* Painless treatment—The CyberKnife® System is painless and requires no anaesthesia,

   effectively eliminating the risk of complications such as infections, haemorrhage and the 

   loss of hearing and/or feeling associated with traditional surgery.  

* No recovery time — Compared to traditional open surgery, CyberKnife® treatments are

   performed on an outpatient basis eliminating overnight hospital stays.  

* Superior comfort—Patients experience improved comfort due to the system’s frameless

   design which eliminates the pain and inconvenience associated with the head or body

   frame used in traditional radiosurgery.  

* Convenience — With an advanced planning system, a patient’s treatment setup can be

   scheduled at the patient’s convenience, and patients can be treated in as few as one to

   five visits.  

 

 

 

How long does treatment take?

 

The patient meets with their consultant, so that the imaging required to plan the treatment (e.g. CT, MRI) and map the tumour can be performed prior to the CyberKnife® treatment.

 

Then the patient visits our new Cancer Centre (open late 2009) for the treatment session that may last anywhere from 30 to 90 minutes. Treatments can be carried out in a single or up to five sessions depending on how the consultant has planned the treatment.

 

 

 

Are CyberKnife® treatments covered by insurance?

 

Accuray and The London Clinic cannot guarantee reimbursement from any private medical insurer (PMI) here or abroad. Data collected from U.S. CyberKnife®Centres indicate that over 100 commercial and private insurance plans are reimbursing in full or partial payments for accredited CyberKnife® services, hospital and consultant fees.  At this time, we are not aware of any UK based PMI providing cover for Cyberknife® treatments.  For more information you should contact your PMI directly.


 

For your queries regarding CyberKnife® treatment at The London Clinic, please contact 

Miss Amanda Hallums, Matron/ Clinical Director of Clinical Services    info@thelondonclinic.co.uk

 

More information about the CyberKnife® Robotic Radiosurgery System

* CyberKnife home page
* CyberKnife patient stories from the USA

* Acurray Incorporated - the developer and manufacturer of the CyberKnife® System.